Croxatto HB, Makirainen L: he pharmacodynamics and eicacy of Implanon. An overview of the data. Contraception 58:915, 1998 Curtis EM, Pine L: Actinomyces in the vaginas of women with and without intrauterine contraceptive devices. Am J Obstet Gynecol 140:880, 1981 Curtis M,Jadaoui TC, Tepper NK, et al: U.S. selected practice recommendations for contraceptive use, 2016. MMWR 65(4):1, 2016a Curtis KM, Tepper NK, Jadaoui TC, et al: U.S. medical eligibility criteria for contraceptive use, 2016. MMWR 65(3):1, 2016b Daniels K, Daugherty J, Jones J, et al: Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. Nat! Health Stat Report 86:1, 2015 Dieben TO, Roumen FJ, Apter 0: Eicacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100:585,2002 Dorlinger LJ: Metabolic efects of implantable steroid contraceptives for women. Contraception 65(1):47, 2002 Dragoman M, Curtis M, Gaield ME: Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes. Contraception 94(3):280, 2016 Drey EA, Reeves MF, Ogawa DO, et al: Insertion of intrauterine contraceptives immediately following first-and second-trimester abortions. Contraception 79(5):397, 2009 Eaton EF, Hoesley CJ: Barrier methods for human immunodeiciency virus prevention. Infect Dis Clin North Am 28(4):585,n2014 Edelman A, Micks E, Gallo MF, et al: Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 7:CD004695, 2014 ESHRE Capri Workshop Group: Venous thromboembolism in women: a speciic reproductive health risk. Hum Reprod Update 19(5):471,n2013 Etminan M, Takkouche B, Isorna FC, et al: Risk ofischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330:63, 2005 European Society of Human Reproduction and Embryology-ESHRE Capri Workshop Group: Ovarian and endometrial function during hormonal contraception. Hum Reprod 16(7):1527,n2001 Farley TM, Rosenberg MJ, Rowe PJ, et al: Intrauterine devices and pelvic inlammatory disease: an international perspective. Lancet 339: 85, 1992 Fehring RJ, Schneider M, Raviele K, et al: Randomized comparison of two internet-supported fertility-awareness-based methods of family planning. Contraception 88(1):24, 2013 Ferguson CA, Costescu 0, Jamieson MA, et al: Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature. Contraception 93(1):81, 2016 FHI 360: Sino-implant (II) project. 2012. Available at: https:llwww.urbanreproductivehealth.org/sites/mle/iles/hi360_factsheecsino-implanc5.30.2012. pd. Accessed July 1, 2016 Finer LB, Zolna MR: Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med 374(9):843, 2016 Food and Drug Administration: Citizen petition partial approval and denial response from FDA COER to state of Wisconsin (Department of Justice). 2015a. Available at: https:llwww.regulations.gov/document?D = FDA2001-P-0123-0188. Accessed October 10, 2016 Food and Drug Administration: FDA approves Plan B One-Step emergency contraceptive for use without a prescription for all women of child-bearing potential. 2013. Available at: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm358082.htm. Accessed June 21, 2016 Food and Drug Administration: FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone. 2012. Available at: http://www.fda.gov/Drugsl DrugSafety/ucm299305.htm. Accessed July 7,n2016 Food and Drug Administration: FDA MedWatch 2004 Safety Alert-DepoProvera (medroxyprogesterone acetate injectable suspension). 2004. Available at: http://www.fda.gov/Safety/MedWatch/Safetylnformation/SafetyAlertsforHumanMedicalProducts/ucm154784.htm. Accessed October 10, 2016